Loving someone with depression that won't lift makes you an amateur researcher overnight. You read things. You hear things from coworkers and relatives. Some of it is right, and some of it quietly steers you wrong at exactly the moment your partner needs clear information.

This piece checks seven beliefs partners commonly hold about drug-free depression treatment. Where it helps, we draw on this summer's survey of 443 Midwest adults, which our publisher commissioned. Its numbers are the final, validated ones.

Belief 1: "If they won't take another pill, they're refusing help"

Mostly false. Wanting to avoid more medication is a mainstream preference, not a sign of giving up. In our survey, a solid majority, 64 percent, said a drug-free option matters to them, and for the 156 respondents with a veteran or first responder in the family, spouses included, it was 72 percent. If your partner is in that group, they are asking for a different kind of help, and that request deserves to be taken seriously rather than argued with.

The real risk is when the preference meets a dead end. If nobody tells your partner what drug-free options exist, "no more pills" can quietly turn into "no more treatment." Your job is to prevent that dead end, not to overrule the preference.

Belief 2: "Drug-free means alternative medicine"

False. Some drug-free treatments are among the most studied in psychiatry. Psychotherapy has decades of research behind it. Transcranial magnetic stimulation, or TMS, has been FDA-cleared since 2008 in adults with major depression that antidepressants have not sufficiently relieved. Electroconvulsive therapy has an even longer track record for severe depression. These are regular clinical treatments, prescribed and supervised by medical professionals.

Supplements, special diets, and wellness retreats are a different category. Some may help with general well-being, but they are not substitutes for evaluated clinical care when depression has resisted treatment.

Belief 3: "If I've never heard of it, it must not be a real option"

False, and very common. Only 25 percent of the people we surveyed knew what TMS was. That leaves three quarters who did not, which is why so many partners assume the menu begins and ends with prescriptions. The treatment is not obscure in medicine. It is obscure in everyday conversation.

Belief 4: "TMS is just a gentler name for shock treatment"

False. The two are different procedures. ECT is done under general anesthesia and uses an electrical current to trigger a brief, controlled seizure. TMS uses a magnetic coil placed against the head while the person sits awake in a chair. No anesthesia is involved, and most patients drive home on their own. Headache and scalp discomfort are the usual side effects. Seizures are a rare risk, which is why clinics screen carefully before starting.

Belief 5: "Ketamine is the natural, drug-free alternative"

False. This one causes real confusion in households. Ketamine and esketamine are drugs.

Spravato, which is esketamine, is a spray used in the nose, approved by the FDA for depression that resists treatment. Only certified clinics give it, and each patient stays under observation for two hours or longer. For some people it is a sensible option to discuss with a doctor, but it is a medication. Brain Recovery Centers explains what Spravato treatment looks like in practice.

Ketamine offered for use at home is another matter again. Those products have no FDA approval for depression. If your partner wants to avoid drugs, pointing them toward any form of ketamine as the "non-pill" answer is likely to feel like a bait and switch.

Belief 6: "Insurance won't pay for anything but pills"

Often false. Therapy is covered by most plans as a mental health benefit. Many commercial plans, as well as Medicare in many areas, cover TMS once certain criteria are met. The usual requirements include a diagnosis of major depression and documentation that several antidepressants have been tried. Each plan sets its own rules, so the details matter.

Coverage shapes decisions for most people. Asked how they would pick a provider, 85 percent of our respondents ranked coverage as one of their two biggest factors. The practical step for a partner is simple: call the member services number on the card and ask for the plan's policy on TMS, then help your partner build a list of the medications they have already tried.

Belief 7: "If I push hard enough, they'll go"

Usually false, and it can backfire. We asked whose influence would most likely lead someone to a new depression treatment. Relatives and friends got 18 percent. The person's own doctor was named by 74 percent. Your opinion carries weight, but it is not the lever that most often moves people.

That is freeing, in a way. You do not have to win the argument. What tends to work better:

• Mention the drug-free option once, calmly, and let it sit.
• Offer to help book an appointment or come along if wanted.
• Help your partner write down their questions for the doctor.
• Take on logistics like scheduling and insurance calls so the path is easier to walk.

One belief that is true

"This is going to take some time and effort." True. A standard TMS course often involves sessions on each weekday for four to six weeks. Therapy tends to run weekly for months. Neither is a one-visit fix, and neither comes with a promise. Planning for the commitment together, including who drives, who covers what at home, and how far the clinic is, is one of the most practical things a partner can do. For 43 percent of the people we asked, a provider near home ranked in the top two.

The bottom line

The biggest myth may be the unspoken one: that the only choice is between another prescription and nothing. For most people, that is not true. But whether any particular treatment fits your partner is for a clinician acquainted with their history to decide. Please read this as information, not medical advice.

Should your partner speak of ending their life, or should you fear they might, reach out today. Dial or text 988 at any hour to talk with the Suicide and Crisis Lifeline, whether the call is for them or for you.

Methodology

This study was commissioned and financed by our publisher. Pollfish's consumer panel was the venue, and the survey closed on June 23, 2026 after 443 people had responded, each an adult 18 to 64 in Indiana, Wisconsin, Kansas, Missouri, Iowa, Nebraska, Ohio, Minnesota, Illinois, or Oklahoma. Numbers here are final; the panel's validation is finished.